Literature DB >> 31028901

Metabolic engineering of Saccharomyces cerevisiae for efficient production of endocrocin and emodin.

Lei Sun1, Guiyou Liu2, Ya Li3, Dayong Jiang4, Wenfeng Guo3, Hui Xu4, Ruoting Zhan4.   

Abstract

The anthraquinones endocrocin and emodin are synthesized by a special class of type I NR-PKSs and a discrete MβL-TE. In this work, we first reconstituted a biosynthetic pathway of endocrocin and emodin in S. cerevisiae by combining enzymes from different sources. We functionally characterized a TE-less NR-PKS (SlACAS) and a MβL-TE (SlTE) from S. lycopersici as well as four orthologous MβL-TEs. SlACAS was coexpressed with different MβL-TEs in S. cerevisiae. SlACAS generated the highest amount of endocrocin when coupled with HyTE, the yield was 115.6% higher than that with the native SlTE. To accumulate more emodin, seven decarboxylases with high homology to HyDC were identified and introduced into the biosynthetic pathway. Among these orthologs, AfDC exhibited the highest catalytic activity and the conversion rate reached 98.6%. A double-point mutant acetyl-CoA carboxylase, ACC1S659A, S1157A, was further introduced to increase the production of malonyl-CoA as a precursor of these anthraquinones. The production of endocrocin (233.6 ± 20.3 mg/L) and emodin (253.2 ± 21.7 mg/L) then dramatically increased. We also optimized the carbon source in the medium and conducted fed-batch fermentation with the engineered strains. The titers of endocrocin and emodin obtained were 661.2 ± 50.5 mg/L and 528.4 ± 62.7 mg/L, respectively, which are higher than previously reported. In this work, by screening a small library of orthologous biosynthetic bricks, an efficient biosynthetic pathway of endocrocin and emodin was first created in S. cerevisiae. This study provides a novel metabolic engineering approach for optimization of the production of desired molecules.
Copyright © 2019 International Metabolic Engineering Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Emodin; Endocrocin; Orthologous biosynthetic bricks; Pathway optimization; Saccharomyces cerevisiae

Mesh:

Substances:

Year:  2019        PMID: 31028901     DOI: 10.1016/j.ymben.2019.04.008

Source DB:  PubMed          Journal:  Metab Eng        ISSN: 1096-7176            Impact factor:   9.783


  6 in total

1.  High-Titer Production of the Fungal Anhydrotetracycline, TAN-1612, in Engineered Yeasts.

Authors:  Pedro A Baldera-Aguayo; Arden Lee; Virginia W Cornish
Journal:  ACS Synth Biol       Date:  2022-06-14       Impact factor: 5.249

Review 2.  The versatile emodin: A natural easily acquired anthraquinone possesses promising anticancer properties against a variety of cancers.

Authors:  Qing Zhang; Wen Wen Chen; Xue Sun; Die Qian; Dan Dan Tang; Li Lin Zhang; Mei Yan Li; Lin Yu Wang; Chun-Jie Wu; Wei Peng
Journal:  Int J Biol Sci       Date:  2022-05-16       Impact factor: 10.750

Review 3.  Research Progress on the Synthetic Biology of Botanical Biopesticides.

Authors:  Jianbo Zhao; Dongmei Liang; Weiguo Li; Xiaoguang Yan; Jianjun Qiao; Qinggele Caiyin
Journal:  Bioengineering (Basel)       Date:  2022-05-12

4.  Enhancement of Emodin Production by Medium Optimization and KH2PO4 Supplementation in Submerged Fermentation of Marine-Derived Aspergillus favipes HN4-13.

Authors:  Xiaohan Qiu; Lizhi Gong; Xiujuan Xin; Faliang An
Journal:  Mar Drugs       Date:  2021-07-26       Impact factor: 5.118

5.  Pathway engineering in yeast for synthesizing the complex polyketide bikaverin.

Authors:  Meng Zhao; Yu Zhao; Mingdong Yao; Hala Iqbal; Qi Hu; Hong Liu; Bin Qiao; Chun Li; Christine A S Skovbjerg; Jens Christian Nielsen; Jens Nielsen; Rasmus J N Frandsen; Yingjin Yuan; Jef D Boeke
Journal:  Nat Commun       Date:  2020-12-03       Impact factor: 14.919

6.  Characterization and Heterologous Expression of UDP-Glucose 4-Epimerase From a Hericium erinaceus Mutant with High Polysaccharide Production.

Authors:  Gen Zou; Juanbao Ren; Di Wu; Henan Zhang; Ming Gong; Wen Li; Jingsong Zhang; Yan Yang
Journal:  Front Bioeng Biotechnol       Date:  2021-11-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.